MIR151B: A Potential Drug Target and Biomarker (G100616247)
MIR151B: A Potential Drug Target and Biomarker
MIR151B, also known as interleukin-18 (IL-18), is a protein that is expressed in various tissues and cells in the body, including immune cells, epithelial cells, and nervous cells. It is a key regulator of inflammation and immune responses, and has been implicated in a number of diseases, including cancer, autoimmune disorders, and chronic obstructive pulmonary disease (COPD).
In recent years, researchers have been interested in exploring the potential of MIR151B as a drug target. MIR151B has been shown to play a role in the regulation of pain perception and inflammation, and has been shown to interact with a number of different proteins, including toll-like receptor 8 (TLR8) and nuclear factor kappa B (NF-kappa-B). This suggests that MIR151B may be a useful target for the development of drugs that can alleviate pain or reduce inflammation.
In addition to its potential as a drug target, MIR151B has also been identified as a potential biomarker for a number of diseases. For example, MIR151B has been shown to be elevated in the bloodstream in individuals with rheumatoid arthritis (RA), a common autoimmune disorder that causes joint inflammation and pain. Additionally, MIR151B has been shown to be elevated in the bloodstream in individuals with heart failure, a condition in which the heart is not able to pump enough blood to meet the body's needs.
MIR151B's role in the regulation of pain and inflammation makes it an attractive target for the development of drugs that can alleviate these symptoms. Currently, there are a number of different drugs that are being developed to target MIR151B, including small molecules, peptides, and monoclonal antibodies. These drugs are being tested in a variety of clinical trials, and while more research is needed, the potential of MIR151B as a drug target is exciting and promising.
In conclusion, MIR151B is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Its role in the regulation of pain and inflammation makes it an attractive target for the development of new treatments. Further research is needed to fully understand the potential of MIR151B as a drug and to develop safe and effective treatments.
Protein Name: MicroRNA 151b
More Common Targets
MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117